Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-11 Sale |
2025-02-12 9:25 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
5,642 | $24.33 | $137,276 | 125,066 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 8:30 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
5,166 | $20.12 | $103,940 | 180,708 (Direct) |
View |
| 2025-01-22 Sale |
2025-01-23 8:35 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
1,584 | $18.94 | $30,002 | 106,374 (Direct) |
View |
| 2024-09-09 Sale |
2024-09-09 9:20 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
2,191 | $11.52 | $25,240 | 107,958 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:05 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
4,195 | $8.5313 | $35,789 | 164,503 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:10 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
1,559 | $9.0684 | $14,138 | 78,698 (Direct) |
View |
| 2023-10-03 Sale |
2023-10-04 4:05 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
3,091 | $8.2511 | $25,504 | 80,257 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-02 7:04 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,779 | $21.75 | $38,697 | 143,319 (Direct) |
View |
| 2023-01-24 Sale |
2023-01-26 4:05 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,550 | $21.9 | $33,952 | 63,598 (Direct) |
View |
| 2022-10-04 Sale |
2022-10-06 8:10 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
3,042 | $25.68 | $78,119 | 65,148 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:18 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,125 | $27.4 | $30,825 | 124,497 (Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 4:36 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,875 | $24.98 | $46,838 | 58,582 (Direct) |
View |
| 2021-10-04 Sale |
2021-10-05 4:06 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
3,058 | $24.77 | $75,746 | 60,457 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-17 7:41 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,407 | $17.12 | $24,086 | 63,515 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 4:31 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
2,250 | $31.5 | $70,864 | 59,344 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-03 9:33 pm |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
1,126 | $29.83 | $33,589 | 57,094 (Direct) |
View |
| 2020-10-02 Sale |
2020-10-05 8:31 pm |
Retrophin Inc. | RTRX | Heerma Peter Chief Commercial Officer |
4,376 | $19.13 | $83,691 | 42,329 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-10 Exercise |
2025-02-12 9:25 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
8,000 | $0 | 125,066 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 8:30 pm |
N/A 2035-01-31 |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
79,500 | $0 | 180,708 (Direct) |
View |
| 2024-09-05 Option Award |
2024-09-09 9:20 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
6,750 | $0 | 107,958 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:05 pm |
N/A 2034-01-30 |
Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER |
90,000 | $0 | 164,503 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 7:04 pm |
N/A 2033-01-30 |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
81,500 | $0 | 143,319 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:18 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
67,040 | $0 | 124,497 (Direct) |
View |
| 2021-08-13 Option Award |
2021-08-17 7:41 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
4,500 | $0 | 63,515 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:48 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
4,500 | $0 | 61,594 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:55 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
72,500 | $0 | 115,720 (Direct) |
View |